Fit to remember? B cell metabolic 'fitness', AMPK & recall antibody responses
适合记住吗?
基本信息
- 批准号:8891563
- 负责人:
- 金额:$ 39.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:5&apos-AMP-activated protein kinaseAddressAdoptive TransferAffinityAllelesAnabolismAntibodiesAntibody FormationAntidiabetic DrugsAntigensB-LymphocytesBiochemicalBiological ModelsBiologyCD8B1 geneCell LineageCell SurvivalCell physiologyCellsCharacteristicsComplementComplexDiseaseEpitopesEquilibriumFosteringGenerationsGlucoseGlycolysisHealthHumoral ImmunitiesHypoxiaImmuneImmune responseImmune systemIn VitroInterleukin-4LeadLearningLeukocytesLifeLipidsLymphoidMaintenanceMeasuresMediatingMemoryMemory B-LymphocyteMetabolicMetabolic PathwayMetabolismMetforminMicrobeModelingMusNutrientOutcomePathway interactionsPerformancePhenotypePhosphotransferasesPhysiologyPlasma CellsPlayPopulationProcessProtein IsoformsProteinsReactionRegulationResearchRoleSTAT6 geneSignal PathwaySignal TransductionSiteStagingStructure of germinal center of lymph nodeSystems DevelopmentT-LymphocyteTestingTissuesTransferaseTransgenesVaccinesadaptive immunityanaerobic glycolysisbasefatty acid oxidationfitnessfunctional outcomesgain of functionlong term memoryloss of functionmTOR proteinmouse modelnoveloxidationresponsesensortranscription factorvaccine efficacy
项目摘要
DESCRIPTION (provided by applicant): Humoral memory is central to the capacity of vaccines to protect against microbes and is a key feature of adaptive immunity. A major determinant of this process is the potency with which germinal center (GC) reactions foster the differentiation and maintenance of memory B cells, which in turn are critical determinants of recall responses. Much has been learned about the potential fates of a B cell after its activation,
including vital contributions of BCR affinity for Ag and other global features of GC reactions, but
remarkably little is known about how signaling within the B cell impacts memory. Accumulating evidence with in vitro manipulations as well as mouse model systems provides indications of a regulatory inter-play of local physiology (e.g., nutrient supply) with signaling in cells of the immune system and their fate or functional characteristics. The unique biology of B cells and memory implies that they use novel metabolic mechanisms. However, very little is known about metabolic regulation for the B lymphoid lineage and especially not for B cell memory or the persistence of adequate concentrations of Ab. AMP-activated kinase (AMPK), the target of anti-diabetic agents such as metformin, is central to regulation of the balance between energy generation versus utilization in bio-synthesis. We have found that the predominant isoform of AMPK in B cells, AMPK�1, promoted the capacity for a recall Ab response in a B cell-intrinsic role. We also developed evidence of a pathway parallel to AMPK, on which an ADP-ribosyl transferase, PARP14, promotes increases in glycolysis, glucose oxidation, and B cell survival. Moreover recall Ab responses of several Ab isotypes depended on PARP14. These and further findings lead us to hypothesize that AMPK� promotes the generation or maintenance of Ag-specific memory B cells, and that this function is exerted at least in part through promotion of metabolic fitness [fatty acid oxidation (FAO) as well as glycolysis and glucose oxidation]. The research also will address an unresolved paradox from key studies of the central paradigm of CTL memory, in which (FAO) is associated with memory fate while glycolysis ties to effector-like phenotype. The conundrum is that the balancing act was attributed to AMPK activity, but this kinase promotes both FAO and glycolysis. We will test the hypothesis that differential regulation of these forms of energy generation is based on mTOR-regulated activity of HIF-1, a transcription factor that may directly repress FAO alongside its activation of glycolysis. To test the impact of AMPK activity on humoral recall, and elucidate a mechanism by which AMPK-driven metabolic pathways can be balanced, we have three specific Aims. The first (Aim 1) is to establish a specific B lineage- intrinsic function for the key metabolic regulator, AMPK, in memory for humoral immunity. Moreover, we plan to test a model in which HIF-1 is integrated with AMPK in setting B cell metabolic balance and recall Ab responses (Aim 2). Finally, we will evaluate if mTOR is an effector of AMPK and HIF-1 in B cells and humoral memory (Aim 3). The expected outcome of the proposed studies is that we will uncover novel roles for AMPK and HIF-1 in determining the metabolic profile in B cells and functional outcome in humoral immunity.
描述:体内记忆是保护疫苗的核心,是VE免疫的关键特征。是召回响应的关键决定因素。
包含BCR亲和力对AG和GC反应的其他全球特征的重要贡献,但
关于撞击记忆中的信号传导知之甚少。记忆的使用l代谢机制。在生物合成中,我们发现了AMPK 1的AMPK的主导者,促进了回忆AB重新恢复的作用。糖酵解,葡萄糖氧化的增加,再召回几个AB几个AB几个AB SEOTYPEND,取决于PARP14。代谢适应性(粮农组织)以及糖酵解和葡萄糖氧化。平衡行为归因于AMPK活性激酶促进粮农组织和糖酵解。 ,阐明了一种机制,通过将AMPK驱动的代谢途径可以平衡,我们有三个特定的目标(AIM 1)是建立谱系的谱系。 1与AMPK整合在设置B细胞中,并回忆AB响应(AM 2),我们将评估MTOR是否是AMPK的效应子,而在B细胞中1的效果(AIM 3)这将揭示作用的发挥作用,即使B细胞中的代谢概况提交了B细胞中的代谢曲线,并在体液mmunity中起作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark R Boothby其他文献
Mark R Boothby的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark R Boothby', 18)}}的其他基金
Antibody quality and germinal center requirements for peroxisomal function in lymphocytes
淋巴细胞过氧化物酶体功能的抗体质量和生发中心要求
- 批准号:
10469589 - 财政年份:2021
- 资助金额:
$ 39.25万 - 项目类别:
Antibody quality and germinal center requirements for peroxisomal function in lymphocytes
淋巴细胞过氧化物酶体功能的抗体质量和生发中心要求
- 批准号:
10318012 - 财政年份:2021
- 资助金额:
$ 39.25万 - 项目类别:
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
TNBC肿瘤细胞谷氨酰胺代谢对抗肿瘤免疫的影响
- 批准号:
10430078 - 财政年份:2020
- 资助金额:
$ 39.25万 - 项目类别:
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
TNBC肿瘤细胞谷氨酰胺代谢对抗肿瘤免疫的影响
- 批准号:
10219207 - 财政年份:2020
- 资助金额:
$ 39.25万 - 项目类别:
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
TNBC肿瘤细胞谷氨酰胺代谢对抗肿瘤免疫的影响
- 批准号:
10656440 - 财政年份:2020
- 资助金额:
$ 39.25万 - 项目类别:
Manipulating & imaging nutrient micro-milieux as B cells effect humoral immunity
操纵
- 批准号:
10529278 - 财政年份:2019
- 资助金额:
$ 39.25万 - 项目类别:
Manipulating & imaging nutrient micro-milieux as B cells effect humoral immunity
操纵
- 批准号:
10062829 - 财政年份:2019
- 资助金额:
$ 39.25万 - 项目类别:
Manipulating & imaging nutrient micro-milieux as B cells effect humoral immunity
操纵
- 批准号:
9889587 - 财政年份:2019
- 资助金额:
$ 39.25万 - 项目类别:
Manipulating & imaging nutrient micro-milieux as B cells effect humoral immunity
操纵
- 批准号:
10306395 - 财政年份:2019
- 资助金额:
$ 39.25万 - 项目类别:
Fit to remember? B cell metabolic 'fitness', AMPK & recall antibody responses
适合记住吗?
- 批准号:
9204785 - 财政年份:2015
- 资助金额:
$ 39.25万 - 项目类别:
相似国自然基金
AMPK通过调控Smurf1的SUMO化抑制创伤性异位骨化的研究
- 批准号:31900852
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
血管微环境中内皮细胞AMPK抑制心肌纤维化的功能与机制研究
- 批准号:81800273
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于AMPK-FXR-BSEP介导的齐墩果酸所致胆汁淤积性肝损伤作用机制研究
- 批准号:81760678
- 批准年份:2017
- 资助金额:35.0 万元
- 项目类别:地区科学基金项目
基于AMPK信号通路研究菝葜黄酮调控脂类代谢分子机制
- 批准号:81760157
- 批准年份:2017
- 资助金额:32.0 万元
- 项目类别:地区科学基金项目
PRKAG2基因自发新突变K485E引起心脏电生理异常的机制研究
- 批准号:81400259
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Decoding AMPK-dependent regulation of DNA methylation in lung cancer
解码肺癌中 DNA 甲基化的 AMPK 依赖性调节
- 批准号:
10537799 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别:
Exercise and muscle mitochondria in Alzheimer's Disease
阿尔茨海默病中的运动和肌肉线粒体
- 批准号:
10740455 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别:
A Randomized Clinical Trial of the Safety and FeasibiLity of Metformin as a Treatment for sepsis induced AKI (LiMiT AKI)
二甲双胍治疗脓毒症引起的 AKI (LiMiT AKI) 的安全性和可行性的随机临床试验
- 批准号:
10656829 - 财政年份:2023
- 资助金额:
$ 39.25万 - 项目类别: